Case Note & Summary
The dispute arose between the Union of India and M/s. Ranbaxy Laboratories Ltd. regarding the price control of the drug Pentazocine. The first respondent, a pharmaceutical company, was granted an exemption from price control under the Drugs (Price Control) Order, 1995, which expired on 31st October 1999. Following the expiry, the Union of India sought to recover an alleged overcharged amount from the company, leading to litigation. The Delhi High Court initially dismissed the company's writ petition, but a Division Bench later allowed the appeal, stating that the exemption Notification applied to drugs manufactured before the expiry date, even if sold afterward. The Union of India contended that the High Court erred in interpreting the exemption, arguing that it only applied to sales and not manufacturing. The first respondent countered that the Notification should be interpreted purposively to allow for practical realities of drug marketing. The Supreme Court ultimately dismissed the appeal, affirming that the exemption Notification was clear and allowed for the sale of drugs manufactured before the expiry date, emphasizing the need for a pragmatic interpretation of the law. The court noted that the manufacturer could not control the timing of sales after dispatching the product. The appeal was dismissed with costs, and the court assessed counsel's fees at Rs. 50,000.
Headnote
A) Administrative Law - Exemption Notification - Applicability of Exemption - Essential Commodities Act, 1955, Section 3 - The court examined whether the exemption Notification allowed the sale of drugs manufactured before the expiry of the exemption period. It held that the exemption applied to drugs manufactured by the company, allowing for a reasonable time for sale post-manufacture, thus dismissing the appeal. (Paras 25-30)
Issue of Consideration
Whether the exemption Notification applies to drugs manufactured and sold after the expiry of the exemption period.
Final Decision
The Supreme Court dismissed the appeal, affirming the applicability of the exemption Notification to drugs manufactured before the expiry date, allowing for a reasonable time for sale.
Law Points
- Price control
- exemption notification
- essential commodities
- purposive construction
- statutory interpretation
